Spyglass Pharma Inc (SGP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 12-2023 | 09-2009 | 06-2009 | 03-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 15,849 | 4,312,000 | 2,989,000 | 2,845,000 |
| Marketable Securities | 0 | 24,468 | 487,000 | 1,411,000 | 708,000 |
| Receivables | 0 | 123 | 3,127,000 | 3,164,000 | 2,953,000 |
| Inventories | 0 | 0 | 3,459,000 | 3,478,000 | 3,158,000 |
| Income taxes - deferred | N/A | N/A | 578,000 | 515,000 | 485,000 |
| Other current assets | 0 | 175 | 0 | 0 | 0 |
| TOTAL | $0 | $40,615 | $13,166,000 | $12,676,000 | $11,344,000 |
| Non-Current Assets | |||||
| PPE Net | N/A | 720 | 6,924,000 | 6,873,000 | 6,662,000 |
| Intangibles | 0 | 0 | 8,860,000 | 8,749,000 | 8,428,000 |
| Other Non-Current Assets | 0 | 86 | 1,597,000 | 1,247,000 | 1,284,000 |
| TOTAL | $N/A | $806 | $17,381,000 | $16,869,000 | $16,374,000 |
| Total Assets | $0 | $41,149 | $30,547,000 | $29,545,000 | $27,718,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 185,000 | 261,000 | 204,000 |
| Accounts payable and accrued liabilities | 0 | 639 | 1,709,000 | 1,755,000 | 1,670,000 |
| Accrued Expenses | 0 | 609 | 967,000 | 828,000 | 838,000 |
| Other current liabilities | 0 | 340 | N/A | N/A | N/A |
| TOTAL | $0 | $1,589 | $5,089,000 | $5,194,000 | $4,961,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 8,033,000 | 7,908,000 | 7,685,000 |
| Other Non-Current Liabilities | 0 | 72,546 | 3,002,000 | 2,910,000 | 2,795,000 |
| TOTAL | $N/A | $72,546 | $12,558,000 | $12,316,000 | $11,922,000 |
| Total Liabilities | $0 | $74,135 | $17,647,000 | $17,510,000 | $16,883,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 1,639,151 | 1,633,939 | 1,628,335 |
| Common Shares | 0 | 0 | 1,066,000 | 1,064,000 | 1,060,000 |
| Retained earnings | 0 | -35,698 | 10,737,000 | 10,368,000 | 9,842,000 |
| Other shareholders' equity | 0 | 0 | 1,140,000 | 790,000 | 148,000 |
| TOTAL | $0 | $-32,986 | $12,900,000 | $12,035,000 | $10,835,000 |
| Total Liabilities And Equity | $0 | $41,149 | $30,547,000 | $29,545,000 | $27,718,000 |